Rescue Turned Strategic Innovation
How we transformed a stalled acquisition into a strategic asset for a pharmaceutical commercialization company, cutting operating costs by 90% and securing their first major post-integration customer.
The Challenge
A pharmaceutical commercialization company acquired a Silicon Valley software business in order to uniquely differentiate their HUB services. However, reality quickly set in:
- Two years after the purchase, the newly acquired digital assets were still completely un-integrated with their existing infrastructure.
- Operating costs remained dangerously high due to inefficient legacy systems and massive software overhead.
- Strategy execution had stalled entirely, risking the core value of the entire software acquisition.
The Solution
Zealic was brought in to turn the stalled integration around. We conducted a rapid financial and operational assessment, instantly identifying critical areas to cut unnecessary costs and revamping the product roadmap to align with real business goals.
We then completely re-architected the platform, modernized the user experience, and established highly scalable, repeatable operations. Within just one month, we stabilized systems and delivered a working demo for a major conference showcase—ultimately enabling the client to recover their value and secure their first major customer post-integration.
Less screen time.
More human impact.
We help life sciences teams tame operational chaos, avoid disruption, and stay focused on what matters most: getting treatments to patients faster.
Contact Us